TABLE OF CONTENTS
Volume 64, Issue 6 (December 1998)
Pharmacokinetics and Drug Disposition |
Clinical Trials and Therapeutics |
Pharmacoepidemiology and Drug Utilization |
Notes of the American Society for Clinical Pharmacology and Therapeutics |
USAN Council |
Author Index
Commentary
The effectiveness of antihistamines in reducing the severity of runny nose and sneezing: A meta-analysis
Ralph B. D'Agostino Sr PhD, Michael Weintraub MD, Heidy K. Russell PhD, Miganush Stepanians PhD, Ralph B. D'Agostino Jr PhD, Louis R. Cantilena Jr MD, PhD, James F. Graumlich MD, Sam Maldonado MD, Peter Honig MD and Charles Anello DSc
Clin Pharmacol Ther 64: 579-596; doi:10.1016/S0009-9236(98)90049-2
Pharmacokinetics and Drug Disposition
Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone
Carol Braun Trapnell MD, Stephen R. Donahue MD, Jerry M. Collins PhD, David A. Flockhart MD, PhD, David Thacker BS and Darrell R. Abernethy MD, PhD
Clin Pharmacol Ther 64: 597-602; doi:10.1016/S0009-9236(98)90050-9
Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
Tarja Heiskanen MD, Klaus T. Olkkola DMedSci and Eija Kalso DMedSci
Clin Pharmacol Ther 64: 603-611; doi:10.1016/S0009-9236(98)90051-0
Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers
Tanya Russell PhD, Maxine Stoltz PhD and Scott Weir PharmD, PhD
Clin Pharmacol Ther 64: 612-621; doi:10.1016/S0009-9236(98)90052-2
Population pharmacokinetic-pharmacodynamic modeling of moxonidine using 24-hour ambulatory blood pressure measurements
Georg Hempel PhD, Mats O. Karlsson PhD, Dinesh P. de Alwis PhD, Nathalie Toublanc PharmD, John McNay MD and Hans G. Schaefer PhD
Clin Pharmacol Ther 64: 622-635; doi:10.1016/S0009-9236(98)90053-4
A model for the turnover of dihydrotestosterone in the presence of the irreversible 5
-reductase inhibitors GI198745 and finasteride
Per Olsson Gisleskog MSc, David Hermann PhD, Margareta Hammarlund-Udenaes PhD and Mats O. Karlsson PhD
Clin Pharmacol Ther 64: 636-647; doi:10.1016/S0009-9236(98)90054-6
Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin
Kari T. Kivistö MD, Kirsti Villikka MD, Leena Nyman MSc, Markku Anttila MSc and Pertti J. Neuvonen MD
Clin Pharmacol Ther 64: 648-654; doi:10.1016/S0009-9236(98)90055-8
Grapefruit juice substantially increases plasma concentrations of buspirone
Jari J. Lilja MD, Kari T. Kivistö MD, Janne T. Backman MD, Tommi S. Lamberg MD and Pertti J. Neuvonen MD
Clin Pharmacol Ther 64: 655-660; doi:10.1016/S0009-9236(98)90056-X
Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole
David J. Greenblatt, Lisa L. von Moltke, Jerold S. Harmatz, Polyxane Mertzanis, Jennifer A. Graf, Anna Liza B. Durol, Molly Counihan, Barbara Roth-Schechter and Richard I. Shader
Clin Pharmacol Ther 64: 661-671; doi:10.1016/S0009-9236(98)90057-1
Clinical Trials and Therapeutics
The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation
Michael D. Hale PhD, Andrew J. Nicholls MD, Roy E.S. Bullingham MD, Ronald Hené MD, A. Hoitsma MD, Jean-Paul Squifflet MD, W. Weimar MD, Yves Vanrenterghem MD, Fokko J. Van de Woude MD and Gert A. Verpooten MD
Clin Pharmacol Ther 64: 672-683; doi:10.1016/S0009-9236(98)90058-3
Pharmacoepidemiology and Drug Utilization
Benzodiazepine use and cognitive function among community-dwelling elderly
Joseph T. Hanlon PharmD, MS, Ronnie D. Horner PhD, Kenneth E. Schmader MD, Gerda G. Fillenbaum PhD, Ingrid K. Lewis PharmD, William E. Wall Jr BA, Lawrence R. Landerman PhD, Carl F. Pieper DrPH, Dan G. Blazer MD, PhD and Harvey Jay Cohen MD
Clin Pharmacol Ther 64: 684-692; doi:10.1016/S0009-9236(98)90059-5
Notes of the American Society for Clinical Pharmacology and Therapeutics
A message from the president: The centennial ASCPT meeting—Come to San Antonio, March 18–20, 1999
Carl C. Peck MD , President
Clin Pharmacol Ther 64: 693-694; doi:10.1016/S0009-9236(98)90060-1
1999 ASCPT clinical pharmacology curriculum review course
Darrell R. Abernethy MD, PhD, Course Co-Director and Raymond L. Woosley MD, PhD, Course Co-Director
Clin Pharmacol Ther 64: 694; doi:10.1016/S0009-9236(98)90061-3
USAN Council
List no. 411: New Names
Clin Pharmacol Ther 64: 695-696; doi:10.1016/S0009-9236(98)90062-5
